AAAAAA
Results:
1-19
|
Results: 19
Authors:
Koch, N
Tamalet, C
Tivoli, N
Fantini, J
Yahi, N
Citation: N. Koch et al., Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase, J CLIN VIRO, 21(2), 2001, pp. 153-162
Authors:
Koch, N
Ndihokubwayo, JB
Yahi, N
Tourres, C
Fantini, J
Tamalet, C
Citation: N. Koch et al., Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): Predominance of subtype C variant, AIDS RES H, 17(3), 2001, pp. 269-273
Authors:
Fantini, J
Tamalet, C
Yahi, N
Citation: J. Fantini et al., Secondary structure predictions of HIV-1 reverse transcriptase provide newinsights into the development of drug-resistance genotypes, AIDS, 15(9), 2001, pp. 1191-1192
Authors:
Koch, N
Yahi, N
Fantini, J
Tamalet, C
Citation: N. Koch et al., Mutations in HIV-1 gag cleavage sites and their association with protease mutations, AIDS, 15(4), 2001, pp. 526-528
Authors:
Yahi, N
Schaefer, RG
Littke, R
Citation: N. Yahi et al., Petroleum generation and accumulation in the Berkine basin, eastern Algeria, AAPG BULL, 85(8), 2001, pp. 1439-1467
Authors:
Yahi, N
Fantini, J
Tourres, C
Tivoli, N
Koch, N
Tamalet, C
Citation: N. Yahi et al., Use of drug resistance sequence data for the systematic detection of non-Bhuman immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale, J INFEC DIS, 183(9), 2001, pp. 1311-1317
Authors:
Hammache, D
Yahi, N
Fantini, J
Citation: D. Hammache et al., Glycosphingolipids and virus-cell fusion: current data highlighting the role of membrane microdomains in the HIV-1 infection cycle, OCL-OL CORP, 7(5), 2000, pp. 449-455
Authors:
Yahi, N
Tamalet, C
Tourres, C
Tivoli, N
Fantini, J
Citation: N. Yahi et al., Mutation L210W of HIV-1 reverse transcriptase in patients receiving combination therapy - Incidence, association with other mutations, and effects onthe structure of mutated reverse transcriptase, J BIOMED SC, 7(6), 2000, pp. 507-513
Authors:
Fantini, J
Maresca, M
Hammache, D
Yahi, N
Delezay, O
Citation: J. Fantini et al., Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signaltransduction pathways and perturbations of intestinal absorption and secretion, GLYCOCON J, 17(3-4), 2000, pp. 173-179
Authors:
Fantini, J
Hammache, D
Pieroni, G
Yahi, N
Citation: J. Fantini et al., Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion, GLYCOCON J, 17(3-4), 2000, pp. 199-204
Authors:
Yahi, N
Tourres, C
Tivoli, N
Colson, P
Dhiver, C
Quinson, AM
Tamalet, C
Citation: N. Yahi et al., Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs, AIDS, 14(18), 2000, pp. 2943-2945
Authors:
Tamalet, C
Pasquier, C
Yahi, N
Colson, P
Poizot-Martin, I
Lepeu, G
Gallais, H
Massip, P
Puel, J
Izopet, J
Citation: C. Tamalet et al., Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection, J MED VIROL, 61(2), 2000, pp. 181-186
Authors:
Hammache, D
Pieroni, G
Maresca, M
Ivaldi, S
Yahi, N
Fantini, J
Citation: D. Hammache et al., Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions, METH ENZYM, 312, 2000, pp. 495-506
Authors:
Tamalet, C
Yahi, N
Tourres, C
Colson, P
Quinson, AM
Poizot-Martin, I
Dhiver, C
Fantini, J
Citation: C. Tamalet et al., Multidrug resistance genotypes (insertions in the beta 3-beta 4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations, VIROLOGY, 270(2), 2000, pp. 310-316
Authors:
Carrieri, MP
Tamalet, C
Vlahov, D
Yahi, N
Chesney, M
Moatti, JP
Citation: Mp. Carrieri et al., Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users, ADDICT BIOL, 4(2), 1999, pp. 197-202
Authors:
Koch, N
Yahi, N
Colson, P
Fantini, J
Tamalet, C
Citation: N. Koch et al., Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis, J VIROL MET, 80(1), 1999, pp. 25-31
Authors:
Koch, N
Yahi, N
Ariasi, F
Fantini, J
Tamalet, C
Citation: N. Koch et al., Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy, J CLIN MICR, 37(5), 1999, pp. 1595-1597
Authors:
Yahi, N
Tamalet, C
Tourres, C
Tivoli, N
Ariasi, F
Volot, F
Gastaut, JA
Gallais, H
Moreau, J
Fantini, J
Citation: N. Yahi et al., Mutation patterns of the reverse transcriptase and protease genes in humanimmunodeficiency virus type 1-infected patients undergoing combination therapy: Survey of 787 sequences, J CLIN MICR, 37(12), 1999, pp. 4099-4106
Authors:
Hammache, D
Yahi, N
Maresca, M
Pieroni, G
Fantini, J
Citation: D. Hammache et al., Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: Evidence for CD4-Induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (gb3 and GM3), J VIROLOGY, 73(6), 1999, pp. 5244-5248
Risultati:
1-19
|